Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synthetic miniprion PrP106.

Valentina Bonetto1, Tania Massignan, Roberto Chiesa

  • 1Dulbecco Telethon Institute, Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri, via Eritrea 62, Milan 20157, Italy. bonetto@marionegri.it

The Journal of Biological Chemistry
|June 12, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model.

Acta neuropathologica·2026
Same author

Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

D178N prion protein mutation endows RML prions with new strain properties that do not mimic human genetic prion diseases.

Acta neuropathologica·2026
Same author

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Brain sciences·2026
Same author

Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer's dementia.

Alzheimer's research & therapy·2026

Researchers synthesized a prion protein fragment (sPrP106) that mimics disease-associated PrP(Sc) properties. This tool aids in studying prion diseases and the conversion of normal cellular prion protein (PrP(C)) into disease forms.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Prion protein scrapie (PrP(Sc)) structure and properties are key to understanding prion diseases.
  • Insolubility and heterogeneity of PrP(Sc) hinder research.
  • A miniprion construct (PrP106) showed protease resistance and prion replication capabilities.

Purpose of the Study:

  • To generate a synthetic peptide (sPrP106) for biochemical and cell culture studies.
  • To investigate the molecular basis of prion protein conformational conversion.
  • To explore the pathogenesis of prion diseases.

Main Methods:

  • Classical stepwise solid-phase synthesis of sPrP106.
  • Purification using a lipophilic chromatographic probe.
  • Biochemical and cell culture assays to characterize sPrP106.

Related Experiment Videos

Main Results:

  • sPrP106 adopted a beta-sheet structure and formed filamentous aggregates.
  • sPrP106 exhibited proteinase K resistance and was toxic to neuronal cultures.
  • sPrP106 increased membrane microviscosity, mimicking PrP(Sc) properties.

Conclusions:

  • sPrP106 serves as an excellent model for studying PrP(Sc).
  • This synthetic peptide facilitates research into prion disease mechanisms.
  • sPrP106 aids in understanding the conversion of PrP(C) to PrP(Sc).